Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract
- PMID: 11786907
- DOI: 10.1038/nm0102-54
Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract
Abstract
Respiratory syncytial virus (RSV) is a major cause of morbidity from respiratory infection in infants, young children and the elderly. No effective vaccine against RSV is currently available and studies of the natural history of RSV infection suggest repeated infections with antigenically related virus strains are common throughout an individual's lifetime. We have studied the CD8+ T-cell response during experimental murine RSV infection and found that RSV inhibits the expression of effector activity by activated RSV-specific CD8+ T cells infiltrating the lung parenchyma and the development of pulmonary CD8+ T-cell memory by interfering with TCR-mediated signaling. These data suggest a possible mechanism to explain the limited duration of protective immunity in RSV infection.
Similar articles
-
Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma.Eur J Immunol. 2002 Aug;32(8):2117-23. doi: 10.1002/1521-4141(200208)32:8<2117::AID-IMMU2117>3.0.CO;2-C. Eur J Immunol. 2002. PMID: 12209623
-
Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity.Eur J Immunol. 2002 Sep;32(9):2562-9. doi: 10.1002/1521-4141(200209)32:9<2562::AID-IMMU2562>3.0.CO;2-4. Eur J Immunol. 2002. PMID: 12207340
-
Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.J Immunol. 2010 Dec 15;185(12):7633-45. doi: 10.4049/jimmunol.0903452. Epub 2010 Nov 17. J Immunol. 2010. PMID: 21084664
-
Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system.Proc Am Thorac Soc. 2005;2(2):141-6. doi: 10.1513/pats.200503-022AW. Proc Am Thorac Soc. 2005. PMID: 16113482 Review.
-
CD8+ T cell immunity against human respiratory syncytial virus.Vaccine. 2014 Oct 21;32(46):6130-7. doi: 10.1016/j.vaccine.2014.08.063. Epub 2014 Sep 16. Vaccine. 2014. PMID: 25223272 Review.
Cited by
-
Contribution of IDO to human respiratory syncytial virus infection.J Leukoc Biol. 2019 Oct;106(4):933-942. doi: 10.1002/JLB.4RU0219-051RR. Epub 2019 May 15. J Leukoc Biol. 2019. PMID: 31091352 Free PMC article. Review.
-
Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice.J Immunol. 2014 Jan 1;192(1):293-9. doi: 10.4049/jimmunol.1300453. Epub 2013 Nov 27. J Immunol. 2014. PMID: 24285837 Free PMC article.
-
Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection.J Immunol. 2014 Nov 15;193(10):5108-17. doi: 10.4049/jimmunol.1302208. Epub 2014 Oct 22. J Immunol. 2014. PMID: 25339663 Free PMC article.
-
Localization of the T-cell response to RSV infection is altered in infant mice.Pediatr Pulmonol. 2018 Feb;53(2):145-153. doi: 10.1002/ppul.23911. Epub 2017 Nov 8. Pediatr Pulmonol. 2018. PMID: 29115050 Free PMC article.
-
The Pneumonia Virus of Mice (PVM) model of acute respiratory infection.Viruses. 2012 Dec;4(12):3494-510. doi: 10.3390/v4123494. Viruses. 2012. PMID: 23342367 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials